Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

202,530 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting Trop2 in solid tumors: a look into structures and novel epitopes.
Liu X, Li J, Deng J, Zhao J, Zhao G, Zhang T, Jiang H, Liang B, Xing D, Wang J. Liu X, et al. Among authors: wang j. Front Immunol. 2023 Dec 20;14:1332489. doi: 10.3389/fimmu.2023.1332489. eCollection 2023. Front Immunol. 2023. PMID: 38179054 Free PMC article. Review.
Clinical advances in TNC delivery vectors and their conjugate agents.
Chen W, Wu Y, Wang J, Yu W, Shen X, Zhao K, Liang B, Hu X, Wang S, Jiang H, Liu X, Zhang M, Xing X, Wang C, Xing D. Chen W, et al. Among authors: wang j, wang s, wang c. Pharmacol Ther. 2024 Jan;253:108577. doi: 10.1016/j.pharmthera.2023.108577. Epub 2023 Dec 9. Pharmacol Ther. 2024. PMID: 38081519 Review.
The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7.
Chen W, Wu X, Hu J, Liu X, Guo Z, Wu J, Shao Y, Hao M, Zhang S, Hu W, Wang Y, Zhang M, Zhu M, Wang C, Wu Y, Wang J, Xing D. Chen W, et al. Among authors: wang j, wang y, wang c. Cardiovasc Diabetol. 2024 Jan 9;23(1):21. doi: 10.1186/s12933-024-02119-z. Cardiovasc Diabetol. 2024. PMID: 38195542 Free PMC article. Review.
Induction PD-1 inhibitor toripalimab plus chemotherapy followed by concurrent chemoradiotherapy and consolidation toripalimab for bulky locally advanced non-small-cell lung cancer: protocol for a randomized phase II trial (InTRist study).
Wang Y, Deng L, Wang J, Zhang T, Wang W, Wang X, Liu W, Wu Y, Lv J, Feng Q, Zhou Z, Wang J, Wang L, Wang Z, Bi N. Wang Y, et al. Among authors: wang x, wang w, wang l, wang j, wang z. Front Immunol. 2024 Jan 15;14:1341584. doi: 10.3389/fimmu.2023.1341584. eCollection 2023. Front Immunol. 2024. PMID: 38288117 Free PMC article.
Efficacy and safety of definitive chemoradiotherapy with or without induction immune checkpoint inhibitors in patients with stage III non-small cell lung cancer.
Yang Y, Wang J, Zhang T, Zhou Z, Wang Y, Jiang Y, Liu W, Xiao Z, Deng L, Feng Q, Wang X, Lv J, Wang W, Xue Q, Wang J, Li YX, Bi N. Yang Y, et al. Among authors: wang x, wang w, wang j, wang y. Front Immunol. 2023 Nov 24;14:1281888. doi: 10.3389/fimmu.2023.1281888. eCollection 2023. Front Immunol. 2023. PMID: 38077319 Free PMC article.
Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity.
Liu L, Li S, Qu Y, Bai H, Pan X, Wang J, Wang Z, Duan J, Zhong J, Wan R, Fei K, Xu J, Yuan L, Wang C, Xue P, Zhang X, Ma Z, Wang J. Liu L, et al. Among authors: wang j, wang z, wang c. Cell Rep Med. 2023 Oct 17;4(10):101206. doi: 10.1016/j.xcrm.2023.101206. Epub 2023 Sep 27. Cell Rep Med. 2023. PMID: 37769655 Free PMC article.
202,530 results
You have reached the last available page of results. Please see the User Guide for more information.